Table: begin end state 1 5 non-cytoplasmic 6 24 transmembrane 25 30 cytoplasmic 31 49 transmembrane 50 53 non-cytoplasmic 54 82 transmembrane 83 102 cytoplasmic 103 123 transmembrane 124 128 non-cytoplasmic 129 151 transmembrane 152 156 cytoplasmic 157 175 transmembrane 176 198 non-cytoplasmic 199 222 transmembrane 223 234 cytoplasmic 235 256 transmembrane 257 261 non-cytoplasmic 262 281 transmembrane 282 313 cytoplasmic 314 336 transmembrane 337 369 non-cytoplasmic 370 387 transmembrane 388 407 cytoplasmic 408 427 transmembrane 428 448 non-cytoplasmic 449 469 transmembrane 470 480 cytoplasmic 481 502 transmembrane 503 503 cytoplasmic 504 506 non-cytoplasmic 507 507 cytoplasmic 508 526 transmembrane 527 537 cytoplasmic 538 558 transmembrane 559 563 non-cytoplasmic 564 580 transmembrane 581 590 cytoplasmic
Input: >WP_006746432.1 NCBI__GCF_000227685.2:WP_006746432.1 MNLGILFLLALMPVATVFVFLVVLRWPAKHAMPLAYVVTAAIALLLWGTDFKVIAAASVH GVVTALNILFIVFGAILLLYTMRESGALQTLRQGFTNISPDRRIQAIIIAWMFGSLIEGS AGFGTPAAVAAPLLVAIGFPAMAAVLSALIIQSTPVSFGAVGTPILVGVNAGLSGQEIVE GHIGDVAFADYLLQIGGNVALLHTLVGFLIPLIMVGMLTRFFGKSRSFREGLKAWKFALF AGVSFTIPYLLVAWLLGPEFPSIVGGLVGLAIVVTAAKKGFLVPKEIFQFEERSRWEPEW ISRFQDQPDPVRTGAAITMVQALIPYIVVVLLLVITRTVEPVTAFLRSPEMTLSWTGIFG TNINTSSQPLYLPGAVLLVASIVTYFLHRMYREKGAYARAWGQSGKTILGASVALLFAVP MVQVFIQSGQASEYASMPLVLAEGVSAMSGSAWPFFSPIIGALGAFIAGSNTVSNMMFSL FQFATAESIGLDANGAAFVVALQAVGGAAGNMICVHNVVAASATVGLIGREGDLIRKALI PMTYYVLAAGALGMAIIYAATLWYVVWVAIVAAFLLFMLWNKGRQPATAV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server